查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941784

美国呼吸系统耐用医疗设备市场规模、份额和趋势分析报告：按产品供应、分销/服务管道、主要州和细分市场预测，2026-2033年

U.S. Respiratory Durable Medical Equipment Market Size, Share & Trends Analysis Report By Product Offering, By Distribution & Service Channel, By Notable States, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 330 Pages | 商品交期: 2-10个工作天内

价格

美国呼吸系统耐用医疗设备市场概述

预计到 2025 年，美国呼吸系统 DME 市场价值将达到 40.1 亿美元，到 2033 年将达到 58.9 亿美元。

预计从 2026 年到 2033 年，该市场将以 4.93% 的复合年增长率成长。这一成长归功于小型化、高效能便携式氧气浓缩机、改进的非侵入性家用人工呼吸器和连网 PAP 呼吸机的技术进步。

此外，中西部许多州慢性呼吸系统疾病（尤其是慢性阻塞性肺病及其相关併发症）的高发生率，加上人口老化、更多人用户联邦医疗保险（Medicare）以及大规模倾向于居家照护的农村患者，共同导致了对制氧机、便携式氧气系统和家用人工呼吸器的持续需求。中西部地区慢性呼吸系统疾病（包括慢性阻塞性肺病、气喘和睡眠呼吸障碍）的盛行率相对较高，这主要是由于人口老化以及某些州吸烟率较高所致。

根据美国肺臟协会统计，到2023年，美国约有1,110万成年人将患有慢性阻塞性肺病（COPD），该疾病仍然是导致发病率和死亡率的主要原因之一，每年造成约500亿美元的医疗保健费用。 COPD日益严重的负担，以及患者需要使用非侵入性通气来控制高碳酸血症、急性加重和睡眠呼吸障碍，都推动了家用和医院用双水平气道正压通气（BiPAP）/持续气道正压通气（VPAP）设备的需求。

俄亥俄州、密西根州、印第安纳州、伊利诺伊州和密苏里州等州的慢性阻塞性肺病（COPD）和阻塞型睡眠呼吸中止症症（OSA）发病率显着较高，这直接推高了对氧气浓缩机、持续性气道正压通气（CPAP）/双水平气道正压通气（BiPAP）机、持续性气道正压通气（CPAP）/双水平气道正压通气（BiPAP）机、持续性呼吸器和辅助通气设备的需求。此外，该地区人口老化导致越来越多的老年人在出院后需要长期呼吸支持和復健护理设备，加速了这些设备的普及。

此外，中西部地区医疗系统、医院和支付方高度重视居家照护和成本控制，这正推动呼吸系统护理从住院环境向居家环境的积极转变，以减少住院时间和避免再入院罚款。这导致长期氧气疗法、睡眠治疗设备以及具备远端患者监护功能的呼吸设备对耐用医疗设备（DME）供应商的依赖性增强。这一趋势主要受联邦医疗保险/医疗补助计划（Medicare/Medicaid）报销机制的推动，该机制鼓励使用居家氧气疗法和睡眠治疗，尤其是在中西部地区以农村和半都市区。此外，中西部地区联邦医疗保险受益人比例相对较高，因此联邦报销政策也是呼吸系统耐用医疗设备需求的重要驱动因素。

例如，内布拉斯加州的支付模式反映了都市区混合人口的呼吸系统特征，其中呼吸机的使用主要依赖医疗补助计划（Medicaid）。这是因为年轻人的睡眠呼吸中止症发生率高于65岁以上。联邦医疗保险（Medicare）仍占有相当大的比例，但由于其主要服务于老年慢性阻塞性肺病（COPD）患者，因此其使用比例较低。同时，氧气浓缩机、人工呼吸器和雾化器也高度依赖联邦医疗保险，这与内布拉斯加州COPD和慢性呼吸系统疾病患者群体老化，且老年人依赖联邦医疗保险的情况相符。私人保险比例较低是因为商业保险在农村地区的普及率较低。

目录

第一章调查方法和范围

第二章执行摘要

3. 美国呼吸系统耐用医疗设备市场：按产品供应情况分類的估算和趋势分析

  • 按产品供应情况分類的波动分析和市占率分析（2024 年和 2033 年）
  • 按产品类型分類的美国呼吸系统耐用医疗设备 (DME) 市场规模估计和预测
    • 睡眠呼吸中止症治疗设备
    • 氧气疗法
    • 雾化治疗设备
    • 口罩、导管、过滤器、耗材
    • 家用和运输用人工呼吸器

第四章 美国呼吸系统耐用医疗设备市场：分销和服务管道的估算和趋势分析

  • 分销和服务管道波动分析及市场份额分析（2024 年和 2033 年）
  • 美国呼吸系统DME市场规模按分销和服务管道分類的估算和预测
    • 全国性DME网络
    • 当地独立人士
    • 医院/家庭护理扩展
    • 线上耐用医疗设备零售商

5. 区域/州级：依细分市场划分，2021-2033 年

  • 中西部
    • 内布拉斯加州
    • 爱荷华州
    • 堪萨斯州
    • 南达科他州
    • 北达科他州
    • 密苏里州
    • 明尼苏达州
    • 威斯康辛州
    • 伊利诺州
    • 科罗拉多
    • 怀俄明州
    • 俄亥俄州
    • 印第安纳州

第六章 竞争分析

  • 参与企业概况
    • 一级（国家耐用医疗设备供应商）
    • 二级供应商（OEM）
    • 第三级（本地独立商家）
  • 财务业绩
    • 一级（国家耐用医疗设备供应商）
    • 二级供应商（OEM）
    • 第三级（本地独立商家）
  • 产品基准测试
    • 一级（国家耐用医疗设备供应商）
    • 二级供应商（OEM）
    • 第三级（本地独立商家）
  • 参与企业
  • 企业市场分析
    • 一级（国家耐用医疗设备供应商）
    • 二级供应商（OEM）
    • 第三级（本地独立商家）
  • 现有市场参与者的退出策略及其对市场竞争对手的影响
    • Medical Depot, Inc. Dba Drive Devilbiss Healthcare
    • Philips Respironics
    • Fisher & Paykel Healthcare
    • Invacare
    • Resmed
    • Medtronic
    • Teleflex Incorporated
    • Breas Medical AB
  • 策略规划
    • 一级（国家耐用医疗设备供应商）
    • 二级供应商（OEM）
    • 第三级（本地独立商家）
  • 其他市场参与者名单
Product Code: GVR-4-68040-845-6

U.S. Respiratory Durable Medical Equipment Market Summary

The U.S. respiratory durable medical equipment (DME) market size was valued at USD 4.01 billion in 2025 and is projected to reach USD 5.89 billion by 2033, growing at a CAGR of 4.93% from 2026 to 2033. This growth is attributed to the technological advances smaller, more efficient portable oxygen concentrators, improved non-invasive home ventilators and connected PAP machines.

In addition, higher chronic respiratory disease prevalence (notably COPD and related comorbidities) in many Midwestern states together with an older, Medicare-heavy population and large rural patient cohorts who prefer home-based care, creates enduring demand for concentrators, portable oxygen systems and home ventilators. The Midwest has a comparatively higher prevalence of chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and sleep-disordered breathing, largely due to an aging population and higher smoking prevalence in certain states.

According to the American Lung Association, in 2023, approximately 11.1 million adults in the United States are living with COPD, which remains a leading cause of morbidity and mortality and is associated with an estimated USD 50 billion in annual healthcare costs. The increasing burden of COPD, combined with the need for non-invasive ventilation to manage hypercapnia, acute exacerbations, and sleep-disordered breathing in these patients, has fueled demand for home and hospital-based BiPAP/VPAP devices.

States such as Ohio, Michigan, Indiana, Illinois, and Missouri report a significant burden of COPD and obstructive sleep apnea (OSA), directly supporting demand for oxygen concentrators, CPAP/BiPAP devices, nebulizers, and ventilatory support equipment. The region's aging demographic profile further accelerates adoption, as older adults are more likely to require long-term respiratory support and post-acute care equipment following hospital discharge.

Moreover, the strong emphasis on home-based care and cost containment across Midwestern healthcare systems, hospitals, and payers is actively shifting respiratory care from inpatient to home settings to reduce length of stay and readmission penalties, increasing reliance on DME providers for long-term oxygen therapy, sleep therapy devices, and remote patient monitoring-enabled respiratory equipment. This trend is fueled by Medicare and Medicaid reimbursement structures, which incentivize home oxygen and sleep therapy utilization, particularly in rural and semi-urban areas that characterize much of the Midwest. In addition, the Midwest has a relatively high proportion of Medicare beneficiaries, making federal reimbursement policies a critical demand driver for respiratory DME volumes.

For instance, Nebraska's payer pattern reflects a mixed urban-rural respiratory profile, where PAP devices tilt toward Medicaid because sleep apnea incidence is higher in the adult, non-elderly population than in the 65+ group. Medicare still contributes substantially but remains secondary as its coverage primarily captures older COPD-dominant cohorts. However, oxygen concentrators, ventilators, and nebulizers lean strongly toward Medicare, consistent with Nebraska's aging COPD and chronic respiratory population that relies more on federal senior coverage. Private plans track smaller shares due to lower employer-sponsored penetration in rural counties.

U.S. Respiratory Durable Medical Equipment Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. respiratory durable medical equipment (DME) market report based on product offerings, distribution & service channel, and Midwest states:

  • Product Offerings Outlook (Revenue, USD Million, 2021 - 2033)
  • Sleep Apnea Devices
    • Auto-titrating CPAP (APAP)
    • Fixed CPAP
    • BiPAP / VPAP
    • Integrated Humidifiers
  • Oxygen Therapy
    • Stationary Oxygen Concentrators
    • Portable Oxygen Concentrators (POCs)
    • Cylinders & Regulators
    • Conservers
  • Nebulizer Equipment
    • Compressor Nebulizers
    • Mesh Nebulizers
    • Drug-specific nebulizers
  • Home & Transport Ventilators
    • Adult/pediatric long-term home ventilators
    • Portable Transport Ventilators
  • Masks, Tubing, Filters & Resupply Items (Consumables)
    • CPAP masks
    • CPAP cushions
    • Oxygen tubing & filters
    • Humidifier chambers
    • Bacterial/viral filters
    • Aerosol delivery accessories
  • Distribution & Service Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • National DME Networks
  • Regional Independents
  • Hospital/IDN Homecare Extensions
  • Online DME Retailers
  • Notable States (Midwest Only) Outlook (Revenue, USD Million, 2021 - 2033)
  • Nebraska (NE)
  • Iowa (IA)
  • Kansas (KS)
  • South Dakota (SD)
  • North Dakota (ND)
  • Missouri (MO)
  • Minnesota (MN)
  • Wisconsin (WI)
  • Illinois (IL)
  • Colorado (CO)
  • Wyoming (WY)
  • Ohio (OH)
  • Indiana (IN)

Table of Contents

Chapter 1 Research Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Regional Scope
    • 1.1.2 Estimates And Forecast Timeline
  • 1.2 Objectives
    • 1.2.1 Objective - 1
    • 1.2.2 Objective - 2
    • 1.2.3 Objective - 3
  • 1.3 List of Secondary Sources
  • 1.4 List of Abbreviation

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Product and End Use Outlook
  • 2.3 Competitive Landscape

Chapter 3 U.S. Respiratory Durable Medical Equipment Market: Product Offering Estimates & Trend Analysis

  • 3.1 U.S. Respiratory Durable Medical Equipment Market: Product Offering Segment Dashboard
  • 3.2 Product Offering Movement & Market Share Analysis, 2024 & 2033
  • 3.3 U.S. Respiratory Durable Medical Equipment Market Size Estimates & Forecast, by Product Offering
    • 3.3.1 Sleep Apnea Devices
      • 3.3.1.1 Sleep Apnea Devices Market, 2021 - 2033 (USD Million)
      • 3.3.1.2 Auto-titrating CPAP
      • 3.3.1.3 Fixed CPAP
      • 3.3.1.4 BiPAP/VPAP (S/T, AVAPS)
      • 3.3.1.5 Integrated Humidifiers
    • 3.3.2 Oxygen Therapy
      • 3.3.2.1 Oxygen Therapy Market, 2021 - 2033 (USD Million)
      • 3.3.2.2 Stationary Oxygen Concentrators
      • 3.3.2.3 Portable Oxygen Concentrators (POCs)
      • 3.3.2.4 Cylinders & regulators
      • 3.3.2.5 Conservers
    • 3.3.3 Nebulizer Therapy Equipment
      • 3.3.3.1 Nebulizer Therapy Equipment Market, 2021 - 2033 (USD Million)
      • 3.3.3.2 Compressor nebulizers
      • 3.3.3.3 Mesh Nebulizers
      • 3.3.3.4 Drug-specific Nebulizers
    • 3.3.4 Masks, Tubing, Filters & Resupply Items (Consumables)
      • 3.3.4.1 Masks, Tubing, Filters & Resupply Items (Consumables) Market, 2021 - 2033 (USD Million)
      • 3.3.4.2 CPAP Masks & Cushions
      • 3.3.4.3 Oxygen tubing & filters
      • 3.3.4.4 Humidifier Chambers
      • 3.3.4.5 Bacterial/Viral (B/V)
      • 3.3.4.6 Aerosol Delivery Accessories
    • 3.3.5 Home & Transport Ventilators
      • 3.3.5.1 Home & Transport Ventilatorsmarket, 2021 - 2033 (USD Million)
      • 3.3.5.2 Adult/Pediatric Long-Term Home Ventilators
      • 3.3.5.3 Portable Ventilators (Transport/ALS)

Chapter 4 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Estimates & Trend Analysis

  • 4.1 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Segment Dashboard
  • 4.2 Distribution & Service Channels Movement & Market Share Analysis, 2024 & 2033
  • 4.3 U.S. Respiratory Durable Medical Equipment Market Size Estimates & Forecast, by Distribution & Service Channels
    • 4.3.1 National Dme Networks
      • 4.3.1.1 National DME Networks market, 2021 - 2033 (USD Million)
    • 4.3.2 Regional Independents
      • 4.3.2.1 Regional Independents Market, 2021 - 2033 (USD Million)
    • 4.3.3 Hospital/Idn Homecare Extensions
      • 4.3.3.1 Hospital/IDN Homecare Extensions Market, 2021 - 2033 (USD Million)
    • 4.3.4 Online Dme Retailers
      • 4.3.4.1 Online DME Retailers Market, 2021 - 2033 (USD Million)

Chapter 5 Regional/State-Level Quantified Deliverables, by Segment, 2021 - 2033, (Revenue, USD Million)

  • 5.1 Midwest
    • 5.1.1 Nebraska
      • 5.1.1.1 Nebraska Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.1.2 Demand & Patient Population
        • 5.1.1.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.1.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.1.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.1.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.1.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.1.3 Supplier Density & Network Mapping
      • 5.1.1.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.1.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.1.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.1.5.1 Sleep Clinics
        • 5.1.1.5.2 Pulmonologists
        • 5.1.1.5.3 Hospitals
        • 5.1.1.5.4 Other providers
      • 5.1.1.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.1.7 Research Methodology
    • 5.1.2 IOWA
      • 5.1.2.1 Iowa Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.2.2 Demand & Patient Population
        • 5.1.2.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.2.2.2 Utilization and healthcare service demand metrics, by sleep apnea devices
        • 5.1.2.2.3 Utilization and healthcare service demand metrics, by nebulizers equipment
        • 5.1.2.2.4 Utilization and healthcare service demand metrics, by home & transport ventilators
        • 5.1.2.2.5 Utilization and healthcare service demand metrics, by oxygen therapy
      • 5.1.2.3 Supplier Density & Network Mapping
      • 5.1.2.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.2.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.2.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.2.5.1 Sleep Clinics
        • 5.1.2.5.2 Pulmonologists
        • 5.1.2.5.3 Hospitals
        • 5.1.2.5.4 Other providers
      • 5.1.2.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.2.1 Research Methodology
    • 5.1.3 KANSAS
      • 5.1.3.1 Kansas Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.3.2 Demand & Patient Population
        • 5.1.3.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.3.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.3.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.3.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.3.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.3.3 Supplier Density & Network Mapping
      • 5.1.3.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.3.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.3.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.3.5.1 Sleep Clinics
        • 5.1.3.5.2 Pulmonologists
        • 5.1.3.5.3 Hospitals
        • 5.1.3.5.4 Other providers
      • 5.1.3.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.3.7 Research Methodology
    • 5.1.4 SOUTH DAKOTA
      • 5.1.4.1 South Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.4.2 Demand & Patient Population
        • 5.1.4.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.4.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.4.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.4.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.4.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.4.3 Supplier Density & Network Mapping
      • 5.1.4.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.4.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.4.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.4.5.1 Sleep Clinics
        • 5.1.4.5.2 Pulmonologists
        • 5.1.4.5.3 Hospitals
        • 5.1.4.5.4 Other providers
      • 5.1.4.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.4.7 Research Methodology
    • 5.1.5 North Dakota
      • 5.1.5.1 North Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.5.2 Demand & Patient Population
        • 5.1.5.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.5.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.5.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.5.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.5.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.5.3 Supplier Density & Network Mapping
      • 5.1.5.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.5.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.5.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.5.5.1 Sleep Clinics
        • 5.1.5.5.2 Pulmonologists
        • 5.1.5.5.3 Hospitals
        • 5.1.5.5.4 Other providers
      • 5.1.5.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.5.7 Research Methodology
    • 5.1.6 Missouri
      • 5.1.6.1 Missouri Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.6.2 Demand & Patient Population
        • 5.1.6.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.6.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.6.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.6.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.6.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.6.3 Supplier Density & Network Mapping
      • 5.1.6.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.6.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.6.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.6.5.1 Sleep Clinics
        • 5.1.6.5.2 Pulmonologists
        • 5.1.6.5.3 Hospitals
        • 5.1.6.5.4 Other providers
      • 5.1.6.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.6.7 Research Methodology
    • 5.1.7 Minnesota
      • 5.1.7.1 Minnesota Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.7.2 Demand & Patient Population
        • 5.1.7.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.7.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.7.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.7.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.7.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.7.3 Supplier Density & Network Mapping
      • 5.1.7.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.7.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.7.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.7.5.1 Sleep Clinics
        • 5.1.7.5.2 Pulmonologists
        • 5.1.7.5.3 Hospitals
        • 5.1.7.5.4 Other providers
      • 5.1.7.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.7.7 Research Methodology
    • 5.1.8 Wisconsin
      • 5.1.8.1 Wisconsin Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.8.2 Demand & Patient Population
        • 5.1.8.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.8.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.8.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.8.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.8.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.8.3 Supplier Density & Network Mapping
      • 5.1.8.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.8.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.8.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.8.5.1 Sleep Clinics
        • 5.1.8.5.2 Pulmonologists
        • 5.1.8.5.3 Hospitals
        • 5.1.8.5.4 Other providers (PCP, ENT, etc.)
      • 5.1.8.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.8.7 Research Methodology
    • 5.1.9 Illinois
      • 5.1.9.1 Illinois Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.9.2 Demand & Patient Population
        • 5.1.9.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.9.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.9.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.9.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.9.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.9.3 Supplier Density & Network Mapping
      • 5.1.9.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.9.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.9.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.9.5.1 Sleep Clinics
        • 5.1.9.5.2 Pulmonologists
        • 5.1.9.5.3 Hospitals
        • 5.1.9.5.4 Other providers (PCP, ENT, etc.)
      • 5.1.9.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.9.7 Research Methodology
    • 5.1.10 Colorado
      • 5.1.10.1 Colorado Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.10.2 Demand & Patient Population
        • 5.1.10.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.10.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.10.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.10.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.10.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.10.3 Supplier Density & Network Mapping
      • 5.1.10.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.10.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.10.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.10.5.1 Sleep Clinics
        • 5.1.10.5.2 Pulmonologists
        • 5.1.10.5.3 Hospitals
        • 5.1.10.5.4 Other providers (PCP, ENT, etc.)
      • 5.1.10.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.10.7 Research Methodology
    • 5.1.11 WYOMING
      • 5.1.11.1 Wyoming Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.11.2 Demand & Patient Population
        • 5.1.11.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.11.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.11.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.11.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.11.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.11.3 Supplier Density & Network Mapping
      • 5.1.11.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.11.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.11.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.11.5.1 Sleep Clinics
        • 5.1.11.5.2 Pulmonologists
        • 5.1.11.5.3 Hospitals
        • 5.1.11.5.4 Other providers (PCP, ENT, etc.)
      • 5.1.11.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.11.7 Research Methodology
    • 5.1.12 OHIO
      • 5.1.12.1 Ohio Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.12.2 Demand & Patient Population
        • 5.1.12.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.12.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.12.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.12.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.12.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.12.3 Supplier Density & Network Mapping
      • 5.1.12.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.12.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.12.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.12.5.1 Sleep Clinics
        • 5.1.12.5.2 Pulmonologists
        • 5.1.12.5.3 Hospitals
        • 5.1.12.5.4 Other providers (PCP, ENT, etc.)
      • 5.1.12.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.12.7 Research Methodology
    • 5.1.13 INDIANA
      • 5.1.13.1 Indiana Respiratory DME Market, 2021 - 2033 (USD Million)
      • 5.1.13.2 Demand & Patient Population
        • 5.1.13.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
        • 5.1.13.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
        • 5.1.13.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
        • 5.1.13.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
        • 5.1.13.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
      • 5.1.13.3 Supplier Density & Network Mapping
      • 5.1.13.4 Reimbursement & Payer Landscape (2024/2025)
        • 5.1.13.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
      • 5.1.13.5 Referral & Clinical Ecosystem (2024/2025)
        • 5.1.13.5.1 Sleep Clinics
        • 5.1.13.5.2 Pulmonologists
        • 5.1.13.5.3 Hospitals
        • 5.1.13.5.4 Other providers (PCP, ENT, etc.)
      • 5.1.13.6 Regulatory & Licensing (Most recent updates to be included)
      • 5.1.13.7 Research Methodology

Chapter 6 Competitive Analysis

  • 6.1 Participant's Overview
    • 6.1.1 Tier 1 (National DME Providers)
    • 6.1.2 Tier 2 (OEM Manufacturers)
    • 6.1.3 Tier 3 (Regional Independents)
  • 6.2 Financial Performance
    • 6.2.1 Tier 1 (National DME Providers)
      • 6.2.1.1 Public Companies
      • 6.2.1.2 Private Companies
    • 6.2.2 Tier 2 (OEM Manufacturers)
      • 6.2.2.1 Public Companies
      • 6.2.2.2 Private Companies
    • 6.2.3 Tier 3 (Regional Independents)
      • 6.2.3.1 Private Companies
  • 6.3 Product Benchmarking
    • 6.3.1 Tier 1 (National DME Providers)
      • 6.3.1.1 Sleep Apnea Devices
      • 6.3.1.2 Oxygen Therapy
        • 6.3.1.2.1 Portable Oxygen Concentrators
        • 6.3.1.2.2 Stationary Oxygen Concentrators
      • 6.3.1.3 Nebulizer Therapy Equipment
      • 6.3.1.4 Masks, Tubing, Filters & Resupply Items (Consumables)
      • 6.3.1.5 Home & Transport Ventilators
    • 6.3.2 Tier 2 (OEM Manufacturers)
      • 6.3.2.1 Sleep Apnea Devices
      • 6.3.2.2 Oxygen Therapy
        • 6.3.2.2.1 Portable Oxygen Concentrators
        • 6.3.2.2.2 Stationary Oxygen Concentrators
      • 6.3.2.3 Nebulizer Therapy Equipment
      • 6.3.2.4 Masks, Tubing, Filters & Resupply Items (Consumables)
      • 6.3.2.5 Home & Transport Ventilators
    • 6.3.3 Tier 3 (Regional Independents)
      • 6.3.3.1 Sleep Apnea Devices
      • 6.3.3.2 Oxygen Therapy
        • 6.3.3.2.1 Portable Oxygen Concentrators
        • 6.3.3.2.2 Stationary Oxygen Concentrators
      • 6.3.3.3 Nebulizer Therapy Equipment
      • 6.3.3.4 Masks, Tubing, Filters & Resupply Items (Consumables)
      • 6.3.3.5 Home & Transport Ventilators
  • 6.4 Participant Categorization
  • 6.5 Company Market Position Analysis
    • 6.5.1 Tier 1 (National DME Providers)
    • 6.5.2 Tier 2 (OEM Manufacturers)
    • 6.5.1 Tier 3 (Regional Independents)
  • 6.6 Exit Strategies of Existing Market Players and Their Impact On Market Competitors
    • 6.6.1 Medical Depot, Inc. Dba Drive Devilbiss Healthcare
      • 6.6.1.1 Medical Depot, Inc. dba Drive DeVilbiss Healthcare's Exit Strategy Aims to Realign the Company with its Mission and Vision
      • 6.6.1.2 Entry of React Health following Medical Depot, Inc. dba Drive DeVilbiss Healthcare's exit and its anticipated impact
    • 6.6.2 Philips Respironics
      • 6.6.2.1 Philips Respironics Exit Strategy Stems from Regulatory Pressure, Reputational Impact, And Portfolio Realignment
    • 6.6.3 Fisher & Paykel Healthcare
      • 6.6.3.1 Exit Strategy of Fisher & Paykel Healthcare for F&P Sleep Style CPAP in the U.S.
    • 6.6.4 Invacare
      • 6.6.4.1 Invacare's Exit Strategy Aims to Realign the Company with Its Mission and Vision.
      • 6.6.4.2 Entry of React Health Following Invacare's Exit and Its Anticipated Impact
    • 6.6.5 Resmed
      • 6.6.5.1 ResMed's Exit Strategy from the Portable Oxygen Concentrator (POC) Market
    • 6.6.6 Medtronic
      • 6.6.6.1 Medtronic Exit Strategy
    • 6.6.7 Teleflex Incorporated
      • 6.6.7.1 Teleflex Incorporated Exit Strategy
    • 6.6.8 Breas Medical AB
      • 6.6.8.1 Breas Medical - Exit Strategy for Z1 & Z2 Series CPAP Devices
  • 6.7 Strategy Mapping
    • 6.7.1 Tier 1 (National DME Providers)
      • 6.7.1.1 Mergers and Acquisitions
      • 6.7.1.2 Collaborations & Partnerships
    • 6.7.2 Tier 2 (OEM Manufacturers)
      • 6.7.2.1 New Product Launch
      • 6.7.2.2 Mergers and Acquisitions
      • 6.7.2.3 Other Strategies
    • 6.7.3 Tier 3 (Regional Independents)
      • 6.7.3.1 Mergers and Acquisitions
  • 6.8 List of Other Market Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Respiratory Durable Medical Equipment Market, by Product Offering, 2021 - 2033 (USD Million)
  • Table 4 U.S. Respiratory Durable Medical Equipment market, by Distribution & Service Channels, 2021 - 2033 (USD Million)
  • Table 5 Reimbursement and Payer Landscape at Each Device Category for Nebraska
  • Table 6 Regulatory & Licensing Framework for Nebraska
  • Table 7 Reimbursement and Payer Landscape at Each Device Category for Iowa
  • Table 8 Regulatory & Licensing Framework for Iowa
  • Table 9 Reimbursement and Payer Landscape at Each Device Category for Kansas
  • Table 10 Regulatory & Licensing Framework for Kansas
  • Table 11 Reimbursement and Payer Landscape at Each Device Category for South Dakota
  • Table 12 Regulatory & Licensing Framework for South Dakota
  • Table 13 Reimbursement and Payer Landscape at Each Device Category for North Dakota
  • Table 14 Regulatory & Licensing Framework for North Dakota
  • Table 15 Reimbursement and Payer Landscape at Each Device Category for Missouri
  • Table 16 Regulatory & Licensing Framework for Missouri
  • Table 17 Reimbursement and Payer Landscape at Each Device Category for Minnesota
  • Table 18 Regulatory & Licensing Framework for Minnesota
  • Table 19 Reimbursement and Payer Landscape for Each Device Category for Wisconsin
  • Table 20 Regulatory & Licensing Framework for Wisconsin
  • Table 21 Reimbursement and Payer Landscape for Each Device Category for Illinois
  • Table 22 Regulatory & Licensing Framework for Illinois
  • Table 23 Reimbursement and Payer Landscape for Each Device Category for Colorado
  • Table 24 Regulatory & Licensing Framework for Colorado
  • Table 25 Reimbursement and Payer Landscape for Each Device Category for Wyoming
  • Table 26 Regulatory & Licensing Framework for Wyoming
  • Table 27 Reimbursement and Payer Landscape for Each Device Category for Ohio
  • Table 28 Regulatory & Licensing Framework for Ohio
  • Table 29 Reimbursement and Payer Landscape for Each Device Category for Indiana
  • Table 30 Regulatory & Licensing Framework for Indiana

List of Figures

  • Fig. 1 U.S. Respiratory DME Market Segmentation
  • Fig. 2 Market snapshot
  • Fig. 3 Product and end use outlook (USD Million)
  • Fig. 4 Competitive landscape
  • Fig. 5 U.S. Respiratory Durable Medical Equipment Market: Product Offering Segment Dashboard
  • Fig. 6 U.S. Respiratory Durable Medical Equipment Market by Product Offering :Market Share Analysis, 2025 & 2033
  • Fig. 7 Sleep Apnea Devices Market, 2021 - 2033 (USD Million)
  • Fig. 8 Oxygen Therapy Market, 2021 - 2033 (USD Million)
  • Fig. 9 Nebulizer Therapy Equipment Market, 2021 - 2033 (USD Million)
  • Fig. 10 Masks, Tubing, Filters & Resupply Items (Consumables) Market 2021 - 2033 (USD Million)
  • Fig. 11 Home & Transport Ventilators Market 2021 - 2033 (USD Million)
  • Fig. 12 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Segment Dashboard
  • Fig. 13 U.S. Respiratory Durable Medical Equipment Market by Distribution & Service Channels : Market Share Analysis, 2025 & 2033
  • Fig. 14 National DME Networks Market, 2021 - 2033 (USD Million)
  • Fig. 15 Regional Independents Market 2021 - 2033 (USD Million)
  • Fig. 16 Hospital/IDN Homecare Extensions Market 2021 - 2033 (USD Million)
  • Fig. 17 Online DME Retailers Market 2021 - 2033 (USD Million)
  • Fig. 18 Nebraska Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 19 Iowa Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 20 Kansas Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 21 South Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 22 North Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 23 Missouri Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 24 Minnesota Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 25 Wisconsin Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 26 Illinois Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 27 Colorado Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 28 Wyoming Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 29 Ohio Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 30 Indiana Respiratory DME Market, 2021 - 2033 (USD Million)
  • Fig. 31 Company/Competition Categorization (Distributors)
  • Fig. 32 Company/Competition Categorization (Manufacturers)
  • Fig. 33 Company Market Position Analysis (Tier 1 (National DME Providers) )
  • Fig. 34 Company Market Position Analysis (Tier 2 (OEM Manufacturers))
  • Fig. 35 Company Market Position Analysis (Tier 3 Regional Independents)
  • Fig. 36 Strategy Mapping (National DME Providers)
  • Fig. 37 Strategy Mapping (OEM Manufacturers)
  • Fig. 38 Strategy mapping (Regional Independents)